COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.

Armagan Berkan Hatice Ecem KonakBahar ÖzdemirHakan ApaydınEbru Atalar Pınar Akyüz Dağlı Serdar Can Güven Abdulsamet ErdenOrhan KüçükşahinAhmet OmmaŞükran Erten

Published in: International journal of rheumatic diseases (2023)

Regardless of the underlying rheumatic disease and organ involvements, hypogammaglobulinemia in ARD could be a risk factor for COVID-19 development, and advanced age could be for COVID-19 severity. Moreover, COVID-19 re-infection rates are high.

Keyphrases

coronavirus disease
sars cov
risk factors
rheumatoid arthritis
respiratory syndrome coronavirus
diffuse large b cell lymphoma
drug induced